These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 27477557)

  • 21. Casebook consults: improving outcomes in gout (multimedia activity).
    Doghramji PP; Mandell BF; Pope RS
    Am J Med; 2012 Aug; 125(8):S1. PubMed ID: 22840678
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Maori experiences and perceptions of gout and its treatment: a kaupapa Maori qualitative study.
    Te Karu L; Bryant L; Elley CR
    J Prim Health Care; 2013 Sep; 5(3):214-22. PubMed ID: 23998172
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Rilonacept (interleukin-1 trap) for prevention of gout flares during initiation of uric acid-lowering therapy: results from a phase III randomized, double-blind, placebo-controlled, confirmatory efficacy study.
    Schumacher HR; Evans RR; Saag KG; Clower J; Jennings W; Weinstein SP; Yancopoulos GD; Wang J; Terkeltaub R
    Arthritis Care Res (Hoboken); 2012 Oct; 64(10):1462-70. PubMed ID: 22549879
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Illness perceptions in patients with gout and the relationship with progression of musculoskeletal disability.
    Dalbeth N; Petrie KJ; House M; Chong J; Leung W; Chegudi R; Horne A; Gamble G; McQueen FM; Taylor WJ
    Arthritis Care Res (Hoboken); 2011 Nov; 63(11):1605-12. PubMed ID: 22034122
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An Observational Study of Gout Prevalence and Quality of Care in a National Australian General Practice Population.
    Robinson PC; Taylor WJ; Dalbeth N
    J Rheumatol; 2015 Sep; 42(9):1702-7. PubMed ID: 26233513
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Knowledge and practice in the management of asymptomatic hyperuricemia among primary health care physicians in Jeddah, Western Region of Saudi Arabia.
    Alqarni NA; Hassan AH
    Saudi Med J; 2018 Dec; 39(12):1218-1225. PubMed ID: 30520504
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Establishment of therapeutic goal and plan of gout and asymptomatic hyperuricemia].
    Fujimori S
    Nihon Rinsho; 2008 Apr; 66(4):729-35. PubMed ID: 18409523
    [TBL] [Abstract][Full Text] [Related]  

  • 28. General practitioners' perspectives on the management of gout: a qualitative study.
    Jeyaruban A; Soden M; Larkins S
    Postgrad Med J; 2016 Oct; 92(1092):603-7. PubMed ID: 27033862
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term persistence and adherence on urate-lowering treatment can be maintained in primary care-5-year follow-up of a proof-of-concept study.
    Abhishek A; Jenkins W; La-Crette J; Fernandes G; Doherty M
    Rheumatology (Oxford); 2017 Apr; 56(4):529-533. PubMed ID: 28082620
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CaseBook challenges: Managing gout, hyperuricemia and comorbidities -- dialogue with the experts.
    Bakris GL; Doghramji PP; Keenan RT; Silber SH
    Am J Med; 2014 Jan; 127(1):S1. PubMed ID: 24268074
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Partners and nurses' knowledge and representations of gout: A qualitative study.
    Deprouw C; Guignot M; Bougeois-Sarran C; Bougeois-Sarran C; Coblentz-Baumann L; Ea HK
    Joint Bone Spine; 2019 Nov; 86(6):769-776. PubMed ID: 31067503
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Concordance of the management of chronic gout in a UK primary-care population with the EULAR gout recommendations.
    Roddy E; Zhang W; Doherty M
    Ann Rheum Dis; 2007 Oct; 66(10):1311-5. PubMed ID: 17504843
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 2011 Recommendations for the diagnosis and management of gout and hyperuricemia.
    Hamburger M; Baraf HS; Adamson TC; Basile J; Bass L; Cole B; Doghramji PP; Guadagnoli GA; Hamburger F; Harford R; Lieberman JA; Mandel DR; Mandelbrot DA; McClain BP; Mizuno E; Morton AH; Mount DB; Pope RS; Rosenthal KG; Setoodeh K; Skosey JL; Edwards NL;
    Postgrad Med; 2011 Nov; 123(6 Suppl 1):3-36. PubMed ID: 22156509
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Managing your patient with gout: a review of treatment options.
    Doghramji PP
    Postgrad Med; 2011 May; 123(3):56-71. PubMed ID: 21566416
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Patients and providers view gout differently: a qualitative study.
    Harrold LR; Mazor KM; Velten S; Ockene IS; Yood RA
    Chronic Illn; 2010 Dec; 6(4):263-71. PubMed ID: 20675361
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Up-to-date management of gout.
    Jordan KM
    Curr Opin Rheumatol; 2012 Mar; 24(2):145-51. PubMed ID: 22301867
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Patient awareness, knowledge and use of colchicine: an exploratory qualitative study in the Counties Manukau region, Auckland, New Zealand.
    Rebello C; Thomson M; Bassett-Clarke D; Martini N
    J Prim Health Care; 2016 Jun; 8(2):140-8. PubMed ID: 27477556
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chronic gout: Barriers to effective management.
    Rogenmoser S; Arnold MH
    Aust J Gen Pract; 2018 Jun; 47(6):351-356. PubMed ID: 29966174
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical efficacy and safety of successful longterm urate lowering with febuxostat or allopurinol in subjects with gout.
    Becker MA; Schumacher HR; MacDonald PA; Lloyd E; Lademacher C
    J Rheumatol; 2009 Jun; 36(6):1273-82. PubMed ID: 19286847
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A world of hurt: failure to achieve treatment goals in patients with gout requires a paradigm shift.
    Khanna P; Khanna D; Storgard C; Baumgartner S; Morlock R
    Postgrad Med; 2016 Jan; 128(1):34-40. PubMed ID: 26578028
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.